You can choose the size of the video you would like to embed below. Next, copy the embed code that is available in the box below. Paste this code on to your website to display the video.
If you experience problems embedding videos, please contact us.
Financial News Network
March 01, 2011 AT 4:15 AM
PDL BioPharma (NASDAQ:PDLI) shares are trading 13.58% higher at $5.52 after the company said it is establishing a regular dividend of $0.15 per share, to be paid in March, June, September and December, according to a Bloomberg report.The company separately said that the company has entered into a settlement agreement with Novartis AG (NYSE:NVS) that resolved all disputes between them.PDL BioPharma has a potential upside of 17.4% based on a current price of $5.54 and an average consensus analyst price target of $6.50.